US equities
|
NVDA
$155.46
▲+0.00%
MU
$712.42
▲+0.00%
SNDK
$797.24
▲+0.00%
AMD
$503.41
▲+0.00%
SKHY
$122.61
▲+0.00%
SPCX
$141.70
▲+0.00%
NBIS
$106.03
▼-0.00%
ASML
$1,383.11
▼-0.00%
NVDA
$155.46
▲+0.00%
MU
$712.42
▲+0.00%
SNDK
$797.24
▲+0.00%
AMD
$503.41
▲+0.00%
SKHY
$122.61
▲+0.00%
SPCX
$141.70
▲+0.00%
NBIS
$106.03
▼-0.00%
ASML
$1,383.11
▼-0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Methamphetamine Use Disorder
Recent news which mentions Methamphetamine Use Disorder
Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment
November 24, 2023
Tags
Global
MDMA treatment
Markets
From
Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
March 28, 2023
Tickers
RVVTF
Tags
Markets
psilocybin therapy
Cannabis
From
Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
March 15, 2023
Tickers
FLHLF
IXHL
SILO
Tags
Penny Stocks
Benzinga
Methamphetamine Use Disorder
From
Benzinga